RE:RE:RE:Turds1:1 ratio of what, sales? Not a great metric for any company, but especially this kind of enterprise.
Not sure where you get the 20% organic growth number. In their own words, they say "increase of 127% driven by acquisitions during the past year and organic growth" but I can't find where they say how much was organic.
Operating cash flow for the first six months was $32,840 (per the WELL financial statements). So, it CAN'T be "tens of millions a quarter". Unless you are ignoring free cash flow and only looking at ADJUSTED EBITDA numbers, which is also an awful metric. And don't forget the most profitable parts of WELL have minority investors who scoop up much of the cash flow. This gets glossed over by pumpers as WELL pulls out tricks from the its bag. If you love ADJUSTED EBITDA as a metric, then note that gross number in Q2 was $26mn, but that the amount that WELL gets was less than $20m, so less than "tens of millions a quarter."
WELL isn't an awful company. But WELL has an enteprise value (still!) at almost a billion dollars. It's not a leap to believe that prices have a way to fall, especially in this environment.
This isn't personal, so make any responses about the company. Or don't, and then we can see whether you are coming at this stock from reason, or emotion.
Noshortsallowed wrote: It's not possible to grow organically at 20% and for share price to fall at a 1:1 ratio with positive cash flow in the tens of millions a quarter. Lowered multiples are one thing but you destroy any credibility you have by just plainly suggesting that WELL could lose another 30% from here.